About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The goal of the Shock, Organic Dysfunction and Resuscitation Research Group (SODIR) is comprehensive, innovative research into the areas of shock, acute respiratory failure, acute kidney failure, organic dysfunction, resuscitation and critical patient monitoring. In addition, the research group has a special interest in applying artificial intelligence as an instrument to find innovative solutions for critical patients.
PMID: 34438993 Journal: Antibiotics-Basel Year: 2021 Reference: Antibiotics (Basel). 2021 Aug 4;10(8). pii: antibiotics10080943. doi: 10.3390/antibiotics10080943. Impact factor: 4.639 Publication type: Paper in international publication Authors: Grau, Santiago, Hernandez, Sergi, Echeverria-Esnal, Daniel, Almendral, Alexander, Ferrer, Ricard, Limon, Enric, Horcajada, Juan Pablo, On Behalf Of The Catalan Infection Control Antimic et al. DOI: 10.3390/antibiotics10080943
PMID: 34413140 Journal: Science Immunology Year: 2021 Reference: Sci Immunol. 2021 Aug 19;6(62). pii: 6/62/eabl4348. doi: 10.1126/sciimmunol.abl4348. Impact factor: 17.727 Publication type: Paper in international publication Authors: Morelle, Guillaume, Asano, Takaki, Boisson, Bertrand, Onodi, Fanny, Shahrooei, Mohammad, Darazam, Ilad Alavi, Olyaei, Nasrin Alipour, Mansouri, Davood, Hatipoglu, Nevin, Palabiyik, Figen et al. DOI: 10.1126/sciimmunol.abl4348
PMID: 34413139 Journal: Science Immunology Year: 2021 Reference: Sci Immunol. 2021 Aug 19;6(62). pii: 6/62/eabl4340. doi: 10.1126/sciimmunol.abl4340. Impact factor: 17.727 Publication type: Paper in international publication Authors: Bastard, Paul, Gervais, Adrian, Le Voyer, Tom, Rosain, Jeremie, Philippot, Quentin, Manry, Jeremy, Michailidis, Eleftherios, Hoffmann, Hans-Heinrich, Eto, Shohei, Garcia-Prat, Marina et al. DOI: 10.1126/sciimmunol.abl4340
PMID: 34366295 Journal: Enfermeria intensiva Year: 2021 Reference: Enferm Intensiva (Engl Ed). 2021 Jul-Sep;32(3):153-163. doi: 10.1016/j.enfie.2020.11.001. Epub 2021 Aug 6. Impact factor: 0 Publication type: Review in national publication Authors: Raurell-Torreda, M, Regaira-Martinez, E, Planas-Pascual, B, Ferrer-Roca, R, Marti, J D, Blazquez-Martinez, E, Ballesteros-Reviriego, G, Vinuesa-Suarez, I, Zariquiey-Esteva, G et al. DOI: 10.1016/j.enfie.2020.11.001
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.
Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.
